In vitro biotransformation of 3-methylmethcathinone (3-MMC) through incubation with human liver microsomes and cytosol and application to in vivo samples.
3-methylmethcathinone (3-MMC)
Human liver cytosol (HLCYT)
Human liver microsomes (HLM)
In vitro metabolisation
In vivo metabolisation
Metaphedrone
Journal
Journal of pharmaceutical and biomedical analysis
ISSN: 1873-264X
Titre abrégé: J Pharm Biomed Anal
Pays: England
ID NLM: 8309336
Informations de publication
Date de publication:
03 Jul 2024
03 Jul 2024
Historique:
received:
31
05
2024
revised:
01
07
2024
accepted:
02
07
2024
medline:
8
7
2024
pubmed:
8
7
2024
entrez:
7
7
2024
Statut:
aheadofprint
Résumé
Synthetic cathinones are the second largest group of new psychoactive substances (NPS) monitored by the European Monitoring Centre for Drugs and Drug Addiction. Although 3-methylmethcathinone (3-MMC, C
Identifiants
pubmed: 38972226
pii: S0731-7085(24)00375-3
doi: 10.1016/j.jpba.2024.116335
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
116335Informations de copyright
Copyright © 2024 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.